Allele: A Division of Catalyst BC

Allele’s core mission is to combine market–proven cannabis genetics with modern agricultural science with the goal of developing commercial cannabis cultivars to maximize product quality and drive financial performance. Allele sources the highest quality genetic material then, integrates genomic mapping and predictive breeding platforms, and utilizes modern tissue culture procedures to provide turnkey genetics solutions that maximize profit and minimize risk for large-scale commercial cannabinoid production.

Genetics Improvement:

Allele will work alongside your cultivation team to identify specific genetic development needs in order to design and implement propagation and breeding programs that will produce unique and proprietary cultivars, providing maximized productivity and profitability. We have developed a dynamic and growing portfolio of unique, exotic and desirable cannabis genetics that exhibit elevated levels of resin content, terpenes, and cannabinoids (THC-A, CBD, CBG, and CBC). Our cultivars have years of proven commercial viability in multiple markets utilizing many types of cultivation methods.  We will work with you to determine your company’s specific genetic needs and implement breeding programs that produce unique and proprietary cultivars that allow you to maximize productivity and profit.  By using the latest genomic mapping, laboratory grade tissue culture and micropropagation techniques we are providing science backed cannabis genetics to a modern market.

Service offerings include:

Award Winning & Proven Cannabis Genetics
Unreleased, Non-Market Exposed Cannabis Genetics
Cannabis Genetics Development
Cannabis Genetics Preservation
Micropropagation (International only)
Targeted Pollination
Seed Production
Genetics Consulting
Genetics Selection
Production Planning

Additional Resources

Consulting Services For Cannabis, Hemp, Psilocybin, and Natural Medicine

Testimonials and Public Relations

Latest Articles

Virginia Cannabis Cultivation License (2027): The Tiered System Explained
For operators whose strength is growing cannabis, Virginia’s emerging adult-use market presents a significant opportunity – and a cultivation license is the gateway to it. The June 2026 framework authorizes the Virginia Cannabis Control Authority (CCA) to begin accepting license applications on or after February 1, 2027 and issuing licenses on or after May 1, 2027. It also establishes five cultivation tiers with maximum canopies ranging from 5,000 to 35,000 square feet.
Virginia Impact Cannabis License (2027): Social Equity & the Equity Business Loan Fund
Virginia’s adult-use cannabis framework creates a meaningful pathway for applicants from communities and backgrounds affected by cannabis prohibition and enforcement. The law does not create a separate, stand-alone impact license. Instead, it creates an impact-licensee designation that qualifying applicants may pursue alongside an underlying marijuana establishment license, such as retail, cultivation, processing, microbusiness, transportation, delivery, or testing.
Virginia Cannabis Microbusiness License (2027): Eligibility & the Two-Location Model
This guide explains the initial eligibility pathways for the licenses the CCA may issue by May 1, 2027, the difference between a microbusiness license and an impact designation, the indoor and outdoor cultivation limits, the precise rules governing two locations, and the financial, security, and operational readiness standards applicants should prepare to demonstrate. Several implementation details – including fees and the specific combination of privileges the CCA will authorize – still depend on forthcoming regulations.
Virginia Dual-Use Cannabis Conversion (2027): The $10M Medical-to-Adult-Use Pathway
For Virginia’s existing medical cannabis operators, the 2026 retail framework created a distinct and high-stakes transition: pharmaceutical processors may apply for verification to exercise dual-use privileges and serve both registered medical patients and adult-use customers. The pathway covers the processor and its permitted cannabis dispensing facilities, and it carries a one-time $10 million fee, a required medical cannabis program preservation plan, an impact-licensee business accelerator commitment, and a firm May 1, 2027 payment or installment-plan deadline.
Virginia Cannabis Facility Design & Build-Out for the 2027 Market
This guide covers the major considerations involved in planning and building a Virginia cannabis facility, with a focus on retail and cultivation operations and additional considerations relevant to processors and microbusinesses. It is written from the build side of the business, because that is where many otherwise-strong applicants stumble: they underestimate utility needs, local approvals, security infrastructure, commissioning, and the time required to convert a site into an inspection-ready operation.
How to Open a Dispensary in Virginia: The 2027 Retail Store License Guide
If you’ve been waiting for the chance to open a cannabis dispensary in Virginia, that chance is now real. With the General Assembly’s June 2026 approval of a regulated retail framework, Virginia is on track to begin adult-use sales on July 1, 2027, and the Cannabis Control Authority (CCA) is expected to open license applications on February 1, 2027.